Christopher T. Rankin

Fc Optimization of Therapeutic Antibodies Enhances Their Ability to Kill Tumor Cells <i>In vitro</i> and Controls Tumor Expansion <i>In vivo</i> via Low-Affinity Activating Fcγ Receptors

Jeffrey B. Stavenhagen, Sergey Gorlatov, Nadine Tuaillon et al. · Cancer Research · 2007 · 269 citations · Full text

Regulation of left-right patterning in mice by growth/differentiation factor-1

Christopher T. Rankin, Tracie E. Bunton, Ann M. Lawler et al. · Nature Genetics · 2000 · 216 citations

Knockout Mouse, Signal Transduction, Developmental Biology +6

CD32B, the human inhibitory Fc-γ receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma

Christopher T. Rankin, Maria-Concetta Verı́, Sergey Gorlatov et al. · Blood · 2006 · 88 citations · Full text

Analytical techniques for cell fractions

Norman G. Anderson, D.A. Waters, W.D. Fisher et al. · Analytical Biochemistry · 1967 · 76 citations

Bioanalysis, Cell Fractions, Cell Culture +4

Enhancing the potency of therapeutic monoclonal antibodies via Fc optimization

Jeffrey B. Stavenhagen, Sergey Gorlatov, Nadine Tuaillon et al. · Advances in Enzyme Regulation · 2007 · 42 citations

Immunocytochemical Technique, Autoimmune Disease, Immunology +8